Welcome to our dedicated page for Lakeside Holding news (Ticker: LSH), a resource for investors and traders seeking the latest updates and insights on Lakeside Holding stock.
Lakeside Holding Limited (LSH), headquartered in Itasca, IL, is a pioneering U.S.-based integrated cross-border supply chain solution provider. The company strategically focuses on the Asian market, including China and South Korea. Lakeside Holding operates under the brand American Bear Logistics, offering customized cross-border ocean freight and airfreight solutions that precisely cater to the needs of its clientele in transporting goods into the United States.
As an Asian American-owned business with deep roots in the U.S., Lakeside Holding Limited boasts an extensive understanding of both U.S. and Asian international trading and logistics service markets. The company's unique position enables it to bridge the gap between these two major economic regions, facilitating seamless trade and logistics operations.
The primary customers of Lakeside Holding Limited are logistics service companies based in Asia and the U.S. These companies serve large e-commerce platforms, social commerce platforms, and manufacturers, aiding in the sale and transportation of consumer and industrial goods produced in Asia into the U.S. This client base underscores the company's critical role in global commerce, ensuring efficient and reliable transportation solutions for a variety of goods.
With a commitment to excellence, Lakeside Holding Limited continues to expand its services and develop innovative logistics solutions. These efforts have cemented its reputation as a trusted partner in the international supply chain, contributing to the global flow of goods and fostering stronger economic ties between Asia and the United States.
Lakeside Holding Limited's recent achievements and current projects highlight its dedication to staying ahead in the competitive logistics industry. By consistently meeting and exceeding customer expectations, the company remains a key player in the cross-border supply chain landscape.
For the latest updates and in-depth information about Lakeside Holding Limited, please stay tuned to this page, which features the most recent news and developments about the company.
Lakeside Holding (Nasdaq: LSH) announced that its subsidiary, Hupan Pharmaceutical, has secured two distribution agreements with Hubei Kelun Pharmaceutical Trading Co., , a subsidiary of Sichuan Kelun Pharmaceutical Co. (002422.SZ). The agreements, effective from January 1, 2025, to December 31, 2025, enable Hupan Pharmaceutical to distribute large-volume parenteral solutions and related medical products to healthcare institutions across China.
This development follows Lakeside's recent agreement with Sichuan Huiyu Pharmaceutical, a specialist in oncology and immune-related therapies, demonstrating the company's growing presence in the pharmaceutical distribution sector. The new partnerships reinforce Hupan Pharmaceutical's ability to establish relationships with major pharmaceutical companies in the industry.
Lakeside Holding (Nasdaq: LSH) has announced that Hupan Pharmaceutical has entered into a strategic distribution agreement with Huiyu Pharmaceutical (Shanghai: 688553.SS). Under the agreement, Hupan Pharmaceutical will distribute Huiyu's oncology and immunotherapy drugs to healthcare institutions in domestic and global markets.
Huiyu Pharmaceutical's flagship product, Pemetrexed Disodium for Injection, has received regulatory approvals in major markets including China, the UK, Germany, and Finland. The product is recognized for treating non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma.
The partnership aims to expand the reach of Huiyu's innovative oncology solutions and deliver life-saving treatments to broader markets through Lakeside's healthcare distribution capabilities.
Lakeside Holding (Nasdaq: LSH) has announced that its subsidiary Hupan Pharmaceutical signed a $1.5 million sales agreement with Sinopharm Holding Hubei New Special Medicine, a subsidiary of Sinopharm Group. The agreement, effective from January 1, 2025, through year-end, covers the delivery of critical medicines including Sodium Bicarbonate, Glucose, and Glucose Sodium Chloride.
This agreement follows a previous partnership with Sinopharm Group focused on medicine storage, transportation, and logistics services, strengthening Hupan Pharmaceutical's position as a pharmaceutical solutions provider in China.
Lakeside Holding (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain solution provider, announced its participation in The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference. The event will take place on December 11th, 2024 at the New York Athletic Club in New York City. CEO Henry Liu will conduct one-on-one meetings with investors and analysts throughout the day. The conference provides emerging growth and dynamic publicly traded companies with opportunities to connect with institutional and individual investors in a unique one-on-one format.
Lakeside Holding (Nasdaq: LSH) announces that its recently acquired subsidiary, Hupan Pharmaceutical, has established a partnership with Sinopharm Group Hubei for pharmaceutical logistics services. The partnership covers essential medicine storage, transportation, and logistics services, including handling refrigerated medications, peptide hormones, and medical supplies. Hupan Pharmaceutical is expected to contribute approximately $7 million in annual revenues to Lakeside. The collaboration strengthens Lakeside's position in China's healthcare market and expands its pharmaceutical logistics capabilities.
Lakeside Holding (LSH) reported Q1 FY2025 results with total revenues decreasing 1.6% to $4.08M from $4.15M in Q1 FY2024. The company saw mixed performance across segments, with cross-border airfreight solutions declining 8.2% to $2.2M, while ocean freight solutions grew 7.8% to $1.8M. Revenue from Asia-based customers surged 65.8% to $2.8M, while U.S.-based customer revenue fell 48.2% to $1.3M. The company reported a net loss of $1.3M compared to $0.3M in the same period last year, with gross margin declining to 12.8% from 15.6%.
Lakeside Holding (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider, has acquired Hupan Pharmaceutical (Hubei) Co., through its subsidiary Sichuan Hupan Jincheng Enterprise Management Co., The acquisition, valued at RMB 4.0 million (US$0.6 million), is expected to add approximately US$7 million in annual revenue to Lakeside. Hupan Pharmaceutical, founded in May 2024 and headquartered in Wuhan, specializes in pharmaceutical distribution and supply chain services, including refrigerated and frozen pharmaceuticals, peptide hormones, and other critical medications. The company holds licenses for drug wholesale, retail, and third-class medical device distribution in China. Hupan Pharmaceutical has partnerships with leading pharmaceutical manufacturers and regional healthcare institutions, including 15 major hospitals in Wuhan. This acquisition strengthens Lakeside's capabilities in the medical logistics sector in China.
Lakeside Holding reported impressive financial results for fiscal year 2024, with total revenues increasing by 42.3% to $18.3 million. This growth was primarily driven by a 117.6% surge in airfreight revenues to $10.4 million, partially offset by a 2.5% decrease in ocean freight revenues. The company's gross profit increased by 44.9% to $3.7 million, with the profit margin rising slightly to 20.3%.
Despite the revenue growth, Lakeside reported a net loss of $0.2 million for the year, compared to a net income of $1.0 million in the previous year. This was largely due to a 77.5% increase in general and administrative expenses to $4.1 million.
The company highlighted several operational achievements, including a successful IPO, new partnerships with e-commerce platforms, and expansion of its Dallas-Fort Worth operations. CEO Henry Liu expressed optimism about future growth opportunities based on these developments and the company's strong performance in cross-border airfreight solutions.
Lakeside Holding (Nasdaq: LSH), operating as American Bear Logistics (ABL), has expanded its Dallas-Fort Worth operations with a new office and warehouse lease. The new facility, at 46,657 square feet, is more than double the size of the previous 20,000 square foot location. This expansion aims to enhance ABL's cross-border logistics solutions and service capacity.
Key aspects of the expansion include:
- Increased space to accommodate more inventory and streamline operations
- Additional staff hired to support expanded operations
- Advanced technology and systems for improved order fulfillment
The move is in response to growing demand for ABL's services and aligns with the company's growth strategy in the Asian market.
Lakeside Holding (Nasdaq: LSH), operating as American Bear Logistics (ABL), has launched a new Pick & Pack Fulfillment service for a major Chinese logistics partner. The service, available at key U.S. hubs including Chicago O'Hare (ORD), Dallas-Fort Worth (DFW), and Los Angeles (LAX) airports, offers streamlined inventory management and order fulfillment. It features real-time inventory data integration, comprehensive order processing, and multi-hub availability.
The service aims to optimize fulfillment, reduce lead times, and enhance customer experience. ABL manages the entire process from inventory check to final delivery, providing an efficient and reliable logistics solution. This new offering is expected to deepen Lakeside's partnership with its client and showcase the company's advanced infrastructure and technology capabilities.